Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangmeng Fu

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Cancer|April 28, 2020
Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencingJiaojiao Zhou, Honglian Wang, Fangmeng Fu, et al.
Journal of Oncology|April 8, 2020
Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsLiuwen Yu, Fangmeng Fu, Jing Li, et al.
Frontiers in Oncology|May 29, 2026
Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysisFangmeng Fu, Li Ma, Fengming Lan, et al.
Pharmacogenomics|December 28, 2020
Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patientsShunmin Huang, Jing Yang, Fangmeng Fu, et al.
Frontiers in Oncology|December 20, 2024
Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in ChinaDuanchong Zhao, Xingxing Yu, Hongli Huang, et al.
Journal of Biophotonics|December 13, 2022
Detection of pathological response of axillary lymph node metastasis after neoadjuvant chemotherapy in breast cancer using multiphoton microscopyZhonghua Han, Xingxin Huang, Deyong Kang, et al.
Breast Cancer Research and Treatment|October 3, 2023
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysisPeng He, Jing Li, Minyan Chen, et al.
Oncotarget|November 9, 2017
Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancerJiantang Zhang, Fangmeng Fu, Yuxiang Lin, et al.
Head & Neck|February 6, 2024
Loco-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real-world retrospective study from two cancer centersLi Ma, Fengming Lan, Peng Chen, et al.
Molecular Imaging and Biology|March 3, 2018
Comparison of [<sup>99m</sup>Tc]3PRGD<sub>2</sub> Imaging and [<sup>18</sup>F]FDG PET/CT in Breast Cancer and Expression of Integrin α<sub>v</sub>β<sub>3</sub> in Breast Cancer Vascular Endothelial CellsZhenying Chen, Fangmeng Fu, Fang Li, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Cancer|April 28, 2020
Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencingJiaojiao Zhou, Honglian Wang, Fangmeng Fu, et al.
Journal of Oncology|April 8, 2020
Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsLiuwen Yu, Fangmeng Fu, Jing Li, et al.
Frontiers in Oncology|May 29, 2026
Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysisFangmeng Fu, Li Ma, Fengming Lan, et al.
Pharmacogenomics|December 28, 2020
Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patientsShunmin Huang, Jing Yang, Fangmeng Fu, et al.
Frontiers in Oncology|December 20, 2024
Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in ChinaDuanchong Zhao, Xingxing Yu, Hongli Huang, et al.
Journal of Biophotonics|December 13, 2022
Detection of pathological response of axillary lymph node metastasis after neoadjuvant chemotherapy in breast cancer using multiphoton microscopyZhonghua Han, Xingxin Huang, Deyong Kang, et al.
Breast Cancer Research and Treatment|October 3, 2023
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysisPeng He, Jing Li, Minyan Chen, et al.
Oncotarget|November 9, 2017
Evaluating the benefits and adverse effects of an enthracycline-taxane-capecitabine combined regimen in patients with early breast cancerJiantang Zhang, Fangmeng Fu, Yuxiang Lin, et al.
Head & Neck|February 6, 2024
Loco-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real-world retrospective study from two cancer centersLi Ma, Fengming Lan, Peng Chen, et al.
Molecular Imaging and Biology|March 3, 2018
Comparison of [<sup>99m</sup>Tc]3PRGD<sub>2</sub> Imaging and [<sup>18</sup>F]FDG PET/CT in Breast Cancer and Expression of Integrin α<sub>v</sub>β<sub>3</sub> in Breast Cancer Vascular Endothelial CellsZhenying Chen, Fangmeng Fu, Fang Li, et al.
Pageof 9